Development of a novel angiotensin converting enzyme 2 stimulator with broad implications in SARS-CoV2 and type 1 diabetes

Angiotensin-converting enzyme 2 (ACE2) is protective in cardiovascular disease, lung injury and diabetes yet paradoxically underlies our susceptibility to SARs-CoV2 infection and the fatal heart and lung disease it can induce. Furthermore, diabetic patients have chronic, systemic inflammation and al...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajapakse, Niwanthi, Nomura, Haru, Wu, Melanie, Song, Jiangning, Hung, Andrew, Tran, Shirley, TA, Hang, Akther, Fahima, Wu, Yuao, Johansen, Matt, Chew, Keng, Kumar, Vinod, Woodruff, Trent, Clark, Richard, Koehbach, Johannes, Lomonte, Bruno, Rosado, Carlos, Thomas, Merlin, Boudes, Marion, Reboul, Cyril, Rash, Lachlan, Gallo, Linda, Essid, Sumia, Elmlund, Dominika, Miemczyk, Stefan, Hansbro, Nicole, Saunders, Bernadette, Britton, Warwick, Sly, Peter, Yamamoto, Ayaho, Fernandez, Julian, Moyle, Peter, Short, Kirsty, Hansbro, Philip, Kuruppu, Sanjaya, Smith, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104254/
https://www.ncbi.nlm.nih.gov/pubmed/37066342
http://dx.doi.org/10.21203/rs.3.rs-2642181/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104254/
https://www.ncbi.nlm.nih.gov/pubmed/37066342
http://dx.doi.org/10.21203/rs.3.rs-2642181/v1

Ejemplares similares